Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Mayo Clinic
Hoffmann-La Roche
STORM Therapeutics LTD
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Radiopharm Theranostics, Ltd
Arvinas Inc.